Newsroom

Blu Build Featured on WTAT-TV in Charleston, SC

The world’s first use of the Blu Build Cesium-131 brachytherapy delivery system to treat prostate cancer at Hollings Cancer Center is an important development for prostate cancer patients and their doctors.  Here’s the...

read more
WKYT: “Lexington cancer doctor saving women’s lives”

WKYT: “Lexington cancer doctor saving women’s lives”

Cesium-131 Brachytherapy pioneer, Dr. Jonathan Feddock was recently featured by WKYT, leading the fight against recurrent gynecologic cancer. “It's estimated every six minutes in this country, a doctor diagnoses a woman with gynecologic cancer or cancer of the...

read more
New guidelines and targeted treatment: insights from AUA 2017

New guidelines and targeted treatment: insights from AUA 2017

Amidst a trove of news surrounding prostate cancer treatment, the 2017 edition of the American Urological Association annual conference convened earlier this month in Boston. The meeting hosted approximately 10,000 attendees and maintained its focus on prostate cancer...

read more
ABS 2017 Insights and Takeaways

ABS 2017 Insights and Takeaways

A thorough discussion on value, detailed brachytherapy delivery techniques and ways clinicians can reach new patients: Isoray’s ABS 2017 insights and takeaways including Dr. Steven Frank, Dr. Alex Hsi and Harvard Business School Professor Emeritus Dr. Robert Kaplan.

read more

IsoRay, Inc. to Present at the Planet MicroCap Showcase 2017

IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced that it will be presenting at the...

read more

Investor Relations:

Mark Levin

Global IR Group
(501) 255-1910

Media and Public Relations:

Sharon Schultz
(302) 539-3747